Invention Grant
- Patent Title: Cancer treatment by MALAT1 inhibition
-
Application No.: US16497566Application Date: 2018-04-09
-
Publication No.: US11359200B2Publication Date: 2022-06-14
- Inventor: JianJun Zhao , Yi Hu , Jing Fang
- Applicant: THE CLEVELAND CLINIC FOUNDATION
- Applicant Address: US OH Cleveland
- Assignee: THE CLEVELAND CLINIC FOUNDATION
- Current Assignee: THE CLEVELAND CLINIC FOUNDATION
- Current Assignee Address: US OH Cleveland
- Agency: Tarolli, Sundheim, Covell & Tummino LLP
- International Application: PCT/US2018/026685 WO 20180409
- International Announcement: WO2018/191153 WO 20181018
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K48/00 ; C12N15/113 ; A61K47/52 ; A61P35/00 ; A61K45/06
Abstract:
Compositions and methods for treating cancer in a subject in need thereof are described that includes administering a therapeutically effective amount of an oligonucleotide that specifically hybridizes to MALAT1.
Public/Granted literature
- US20210102212A1 CANCER TREATMENT BY MALAT1 INHIBITION Public/Granted day:2021-04-08
Information query
